• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在前列腺放疗期间将神经血管束剂量降至最低的挑战与机遇。

Challenges and opportunities to minimize the dose in the neurovascular bundles during prostate radiotherapy.

作者信息

Brand Victor J, Rossi Linda, Milder Maaike T W, Froklage Femke E, Tree Alison C, Hoogeman Mischa S, Incrocci Luca

机构信息

Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Department of Radiotherapy, UK.

The Royal Marsden Hospital, London, UK.

出版信息

Clin Transl Radiat Oncol. 2025 Apr 9;53:100959. doi: 10.1016/j.ctro.2025.100959. eCollection 2025 Jul.

DOI:10.1016/j.ctro.2025.100959
PMID:40270948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12018000/
Abstract

BACKGROUND AND PURPOSE

Radiation damage to the neurovascular bundles (NVB) has been linked to erectile dysfunction after prostate cancer radiotherapy (PCa). NVB sparing using coplanar and non-coplanar automated treatment planning is presented here in two settings: (1) without compromising target coverage, (2) allowing target coverage compromise.

MATERIAL AND METHODS

20 previously treated patients with localized PCa. Based on a MRI-CT match, the NVB were retrospectively delineated. All treatment plans (5 × 7.25 Gy) were automatically generated using Erasmus-iCycle (in-house automated treatment planning algorithm). Non-NVB sparing (non-NVBsparing) plans and NVB sparing plans in two settings were generated: (1) uncompromised NVB sparing (u-NVBsparing; maintaining target coverage) (2) and compromised NVB sparing (c-NVBsparing; allowing target underdosage). Coplanar and non-coplanar beam arrangements were compared. U-NVBsparing was compared to non-NVBsparing. C-NVBsparing plans were visualized in Pareto fronts. Statistical significance (p-value < 0.05) was determined by Wilcoxon signed-rank test.

RESULTS

u-NVBsparing compared to non-NVBsparing plans showed statistically significant median reductions in NVB D0.1 cc (38.9 vs 42.6 Gy for coplanar; 38.9 vs 43.3 Gy for non-coplanar) and Dmean (25.6 vs 30.0 Gy for coplanar; 24.7 vs 30.2 Gy for noncoplanar). Further lowering NVB D0.1 cc in c-NVBsparing plans clearly correlated to lower target coverage. Non-coplanar c-NVBsparing plans maintained significantly higher target coverages for similar NVB D0.1 cc values, compared to coplanar plans.

CONCLUSION

NVB sparing without compromising target coverage is feasible. No clinically relevant benefit was found for non-coplanar compared to coplanar NVB sparing plans, although overall statistically superior. Further sparing of the NVB comes at the cost of target coverage, for which a Pareto front could be used as a tool in clinical practise.

摘要

背景与目的

前列腺癌放疗(PCa)后神经血管束(NVB)的放射性损伤与勃起功能障碍有关。本文介绍了在两种情况下使用共面和非共面自动治疗计划来保留NVB:(1)不影响靶区覆盖,(2)允许靶区覆盖妥协。

材料与方法

20例既往接受过治疗的局限性PCa患者。基于MRI-CT匹配,对NVB进行回顾性勾画。所有治疗计划(5×7.25 Gy)均使用伊拉斯谟-iCycle(内部自动治疗计划算法)自动生成。生成了非NVB保留(非NVBsparing)计划和两种情况下的NVB保留计划:(1)无妥协的NVB保留(u-NVBsparing;维持靶区覆盖)(2)和妥协的NVB保留(c-NVBsparing;允许靶区剂量不足)。比较了共面和非共面射束排列。将u-NVBsparing与非NVBsparing进行比较。c-NVBsparing计划在帕累托前沿进行可视化。通过Wilcoxon符号秩检验确定统计学显著性(p值<0.05)。

结果

与非NVBsparing计划相比,u-NVBsparing显示NVB D0.1 cc(共面时为38.9 vs 42.6 Gy;非共面时为38.9 vs 43.3 Gy)和Dmean(共面时为25.6 vs 30.0 Gy;非共面时为24.7 vs 30.2 Gy)的中位数有统计学显著降低。在c-NVBsparing计划中进一步降低NVB D0.1 cc与较低的靶区覆盖明显相关。与共面计划相比,非共面c-NVBsparing计划在相似的NVB D0.1 cc值下维持了显著更高的靶区覆盖。

结论

在不影响靶区覆盖的情况下保留NVB是可行的。与共面NVB保留计划相比,非共面计划虽总体在统计学上更优,但未发现临床相关益处。进一步保留NVB是以靶区覆盖为代价的,为此帕累托前沿可作为临床实践中的一种工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/c3e0c0424e4e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/cdf5553c669d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/9e33b6802fc9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/8834c55cbb02/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/c3e0c0424e4e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/cdf5553c669d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/9e33b6802fc9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/8834c55cbb02/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/12018000/c3e0c0424e4e/fx1.jpg

相似文献

1
Challenges and opportunities to minimize the dose in the neurovascular bundles during prostate radiotherapy.在前列腺放疗期间将神经血管束剂量降至最低的挑战与机遇。
Clin Transl Radiat Oncol. 2025 Apr 9;53:100959. doi: 10.1016/j.ctro.2025.100959. eCollection 2025 Jul.
2
Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.前列腺周围水凝胶间隔物保神经血管束的立体定向体部放射治疗局部前列腺癌保留勃起功能的剂量学可行性。
Br J Radiol. 2021 Mar 1;94(1119):20200433. doi: 10.1259/bjr.20200433. Epub 2021 Feb 15.
3
Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.适应性磁共振引导下保留神经血管的放射治疗以保留前列腺癌患者的勃起功能
Phys Imaging Radiat Oncol. 2021 Sep 21;20:5-10. doi: 10.1016/j.phro.2021.09.002. eCollection 2021 Oct.
4
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.在针对局限性前列腺癌的神经血管保留磁共振引导放疗中,神经血管束和阴部内动脉轮廓勾画的评分者间一致性。
Clin Transl Radiat Oncol. 2021 Nov 14;32:29-34. doi: 10.1016/j.ctro.2021.11.005. eCollection 2022 Jan.
5
Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study.使用MRI-CT配准的保留神经血管束的前列腺癌放射治疗:剂量学可行性研究。
Med Dosim. 2016;41(4):339-343. doi: 10.1016/j.meddos.2016.08.003. Epub 2016 Oct 13.
6
Neurovascular bundle sparing in hypofractionated radiotherapy maintained with realistic treatment uncertainties.在考虑实际治疗不确定性的情况下,在大分割放疗中保留神经血管束。
Phys Imaging Radiat Oncol. 2025 Jan 30;33:100714. doi: 10.1016/j.phro.2025.100714. eCollection 2025 Jan.
7
Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment.神经血管保护的磁共振引导自适应放疗在前列腺癌中的应用;为保留性功能治疗定义潜在人群。
J Sex Med. 2022 Jul;19(7):1196-1200. doi: 10.1016/j.jsxm.2022.04.006. Epub 2022 May 23.
8
Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.采用立体定向体部放疗对胸腰椎转移瘤进行容积调强弧形治疗计划。
J Appl Clin Med Phys. 2018 Mar;19(2):54-61. doi: 10.1002/acm2.12252. Epub 2018 Jan 19.
9
Automated generation of IMRT treatment plans for prostate cancer patients with metal hip prostheses: comparison of different planning strategies.金属髋部假体前列腺癌患者调强放疗计划的自动生成:不同计划策略的比较。
Med Phys. 2013 Jul;40(7):071704. doi: 10.1118/1.4808117.
10
Complementing Prostate SBRT VMAT With a Two-Beam Non-Coplanar IMRT Class Solution to Enhance Rectum and Bladder Sparing With Minimum Increase in Treatment Time.用两束非共面调强放射治疗(IMRT)类解决方案补充前列腺立体定向体部放疗(SBRT)容积调强弧形放疗(VMAT),以在治疗时间增加最少的情况下增强直肠和膀胱的保护。
Front Oncol. 2021 Mar 19;11:620978. doi: 10.3389/fonc.2021.620978. eCollection 2021.

本文引用的文献

1
Urethra-Sparing Prostate Cancer Stereotactic Body Radiation Therapy: Sexual Function and Radiation Dose to the Penile Bulb, the Crura, and the Internal Pudendal Arteries From a Randomized Phase 2 Trial.保留尿道的前列腺癌立体定向体部放射治疗:来自一项随机 2 期试验的阴茎球部、阴茎脚和阴部内动脉的性功能和放射剂量
Int J Radiat Oncol Biol Phys. 2024 Jul 15;119(4):1137-1146. doi: 10.1016/j.ijrobp.2023.12.037. Epub 2023 Dec 29.
2
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review.保留前列腺癌放疗中的性结构:系统评价。
Eur Urol Oncol. 2024 Jun;7(3):332-343. doi: 10.1016/j.euo.2023.08.003. Epub 2023 Aug 26.
3
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.
从每周一次到半周一次全前列腺立体定向放疗联合局灶加量:多中心 Hypo-FLAME 2.0 试验的主要终点分析。
Radiother Oncol. 2023 Aug;185:109713. doi: 10.1016/j.radonc.2023.109713. Epub 2023 May 11.
4
Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer.临床局限性前列腺癌患者采用保留勃起组织的强度调制放疗的 3 期随机前瞻性试验的长期结果。
Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1074-1084. doi: 10.1016/j.ijrobp.2022.12.008. Epub 2022 Dec 23.
5
Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment.神经血管保护的磁共振引导自适应放疗在前列腺癌中的应用;为保留性功能治疗定义潜在人群。
J Sex Med. 2022 Jul;19(7):1196-1200. doi: 10.1016/j.jsxm.2022.04.006. Epub 2022 May 23.
6
Longitudinal Changes in U.S. Parameters of Neurovascular Bundles Suggest Mechanism for Radiation-Induced Erectile Dysfunction.美国神经血管束参数的纵向变化提示辐射诱导勃起功能障碍的机制。
Adv Radiat Oncol. 2022 Mar 19;7(5):100946. doi: 10.1016/j.adro.2022.100946. eCollection 2022 Sep-Oct.
7
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.剂量递增外照射治疗局限性前列腺癌对生活质量的影响:前瞻性随机 3 期临床试验 NRG/RTOG 0126 的结果。
Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):83-92. doi: 10.1016/j.ijrobp.2021.07.004.
8
Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.适应性磁共振引导下保留神经血管的放射治疗以保留前列腺癌患者的勃起功能
Phys Imaging Radiat Oncol. 2021 Sep 21;20:5-10. doi: 10.1016/j.phro.2021.09.002. eCollection 2021 Oct.
9
Complementing Prostate SBRT VMAT With a Two-Beam Non-Coplanar IMRT Class Solution to Enhance Rectum and Bladder Sparing With Minimum Increase in Treatment Time.用两束非共面调强放射治疗(IMRT)类解决方案补充前列腺立体定向体部放疗(SBRT)容积调强弧形放疗(VMAT),以在治疗时间增加最少的情况下增强直肠和膀胱的保护。
Front Oncol. 2021 Mar 19;11:620978. doi: 10.3389/fonc.2021.620978. eCollection 2021.
10
Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.前列腺周围水凝胶间隔物保神经血管束的立体定向体部放射治疗局部前列腺癌保留勃起功能的剂量学可行性。
Br J Radiol. 2021 Mar 1;94(1119):20200433. doi: 10.1259/bjr.20200433. Epub 2021 Feb 15.